Your search returned 8 results.

Results
	1.	Targeted therapy in colorectal cancer: current status and future challenges. [electronic resource] by Koutras, A K Starakis, I Kyriakopoulou, U Katsaounis, P Nikolakopoulos, A Kalofonos, H P Producer: 20110818 In: Current medicinal chemistry vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG). [electronic resource] by Katsaounis, P Kotsakis, A Agelaki, S Kontopodis, E Agelidou, A Kentepozidis, N Vamvakas, L Christopoulou, A Karachaliou, N Hatzidaki, D Georgoulias, V Producer: 20150526 In: Cancer chemotherapy and pharmacology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG). [electronic resource] by Mavroudis, D Matikas, A Malamos, N Papakotoulas, P Kakolyris, S Boukovinas, I Athanasiadis, A Kentepozidis, N Ziras, N Katsaounis, P Saloustros, E Georgoulias, V Producer: 20171222 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG). [electronic resource] by Kentepozidis, N Economopoulou, P Christofyllakis, Ch Chelis, L Polyzos, A Vardakis, N Koinis, F Vamvakas, L Katsaounis, P Kalbakis, K Nikolaou, Ch Georgoulias, V Kotsakis, A Producer: 20170302 In: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy. [electronic resource] by Kotsakis, A Matikas, A Koinis, F Kentepozidis, N Varthalitis, I I Karavassilis, V Samantas, Ep Katsaounis, P Dermitzaki, E K Hatzidaki, D Mavroudis, D Georgoulias, V Producer: 20170623 In: British journal of cancer vol. 115 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group. [electronic resource] by Koinis, F Agelaki, S Karavassilis, V Kentepozidis, N Samantas, E Peroukidis, S Katsaounis, P Hartabilas, E Varthalitis, I I Messaritakis, I Fountzilas, G Georgoulias, V Kotsakis, A Producer: 20170828 In: British journal of cancer vol. 117 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG). [electronic resource] by Matikas, A Kentepozidis, Ν Ardavanis, A Vaslamatzis, M Polyzos, A Emmanouilides, Ch Katsaounis, P Koinis, F Xynogalos, S Christopoulou, A Ziras, N Tegos, Th Prinarakis, E Hatzidaki, D Georgoulias, V Kotsakis, A Producer: 20170606 In: Cancer chemotherapy and pharmacology vol. 78 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first-line therapy for advanced or metastatic non-squamous non-small cell lung cancer: A multicenter randomized phase II trial of the Hellenic Oncology Research Group (HORG). [electronic resource] by Kotsakis, A Kentepozidis, N Emmanouilidis, Ch Polyzos, A Agelidou, A Vaslamatzis, M Chandrinos, V Agelaki, S Vamvakas, L Kalbakis, K Katsaounis, P Stoltidis, D Nintos, G Hatzidaki, D Vetsika, E K Mavroudis, D Georgoulias, V Producer: 20151201 In: Lung cancer (Amsterdam, Netherlands) vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)